Lifetime health care costs of oropharyngeal cancer for commercially insured patients in the United States.

Chi-Fang WuDavid R LairsonKristina R DahlstromJoël Fokom DomgueShuangshuang FuErich M SturgisWenyaw Chan

Published in: Head & neck (2020)

Our study included 2445 patients with OPC. The predicted phase-specific lifetime health care costs attributable to OPC were $88 872, $24 038, and $1537 in the initial, continuous, and terminal phases, respectively, among commercially insured patients.

Keyphrases

healthcare
end stage renal disease
newly diagnosed
ejection fraction
patient reported outcomes
patient reported
social media
papillary thyroid
health insurance
squamous cell